(ii) Peptide vaccines. In a similar preclinical study, an NGS and MHC Class I prediction model was used to identify MHC Class I-restricted CD8+ T cell reactive neoepitopes in a mouse sarcoma model [101]. The gene discussed is CD8A; the disease is sarcoma.